Advanced search

Global

Feed details

Industry: Pharmaceuticals

Subscribe to future episodes

Select a service to subscribe to

Or right-click the URL below, select 'Copy Shortcut' from the menu, and paste it into your newsreader.

http://www.kpmg.com/Global/Iss ...

Global - Issues & insights - RSS Feeds - Pharmaceuticals

Pharmaceuticals

Keep up with new developments added to this site by subscribing to our Pharmaceuticals feed.

To subscribe to this feed, right-click on the URL at the bottom of the left-hand column, select 'Copy Shortcut' and paste it into your newsreader.

Feed Contents

KPMG's Risk and Disclosures Handbook 2008-2009: Global Pharmaceuticals, Medical Devices and Diagnostics, and Biotechnology Industries

KPMG has analyzed and compared some of the largest companies in the Pharmaceutical, Medical Devices and Diagnostics, and Biotechnology industries for the 2008-2009 reporting season. This year we have produced three standalone volumes.

The tablet: KPMG's views on the future of M&A in the pharmaceutical and biotech industries

Pharmaceutical companies face a period of uncertain financial health. This edition of The tablet seeks to explore if M&A activity can provide a key tool for companies to respond to these challenges and play a role in improving the industry's future.

Issues monitor: Pharmaceuticals — July 2009

This edition looks at M&A in the global pharmaceuticals and biotechnology sectors, the changing landscape of the pharmaceuticals sales force, and IT outsourcing.

Issues monitor: Pharmaceuticals — April 2009

This edition includes articles on the integration of pharmaceuticals and healthcare, the biotech industry under pressure from the financial crisis, and the use of information technology in clinical trials.

The Tablet: KPMG's views on the new public policy environment in the United States: The impact on pharmaceutical and medical device companies

Change in healthcare policy is inevitable under the Obama administration.This eight-page special explores the impact of the new U.S. political environment on the pharmaceutical and medical devices industries.

The Tablet: EU competition authorities' recent focus on the pharmaceutical industry

This edition of The Tablet highlights the recent scrutiny of the EU competition authorities on the pharmaceutical sector and steps companies should be prepared to take in response to information requests.

Issues monitor — pharmaceuticals volume four — January 2009

This edition of Issues Monitor looks at supply chain management and tax efficiency and the drug discovery industry in China and India.

Issues monitor — pharmaceuticals volume three — December 2008

This edition of Issues Monitor focuses on preparing for generics competition.

Issues monitor — pharmaceuticals volume one — December 2008

This edition of Issues Monitor focuses on cost optimization — manufacturing rationalization

Issues monitor — pharmaceuticals volume two — December 2008

This edition of Issues Monitor looks at enterprise risk management in the evolving pharmaceutical industry.

Subscribe to selected content and receive email alerts when new content is available for viewing on this site.

Already a member? Login

Not a member? Register

Or find a contact in your location

© 2009 KPMG International. KPMG International is a Swiss cooperative. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.